HolderBook

Seven Fleet Capital Management LP

Reported holdings as of Q2 2026, from 3 quarterly filings.

CIK
2092021
Reported value
$605.9M
Positions
96
Top 10 weight
65.1%
Filed
2026-08-17
Days after quarter end
48

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
CG ONCOLOGY INCCGON$134.0M1,886,23622.12%+20.49pp3q+2389.8%+$128.6M
TANGO THERAPEUTICS INCTNGX$95.7M3,228,14415.79%+12.45pp3q+543.0%+$80.8M
REVOLUTION MEDICINES INCRVMD$45.3M242,0297.48%+4.99pp3q+199.6%+$30.2M
PHARVARIS N VPHVS$26.8M774,5014.42%+2.87pp3q+348.4%+$20.8M
LIQUIDIA CORPORATIONLQDA$20.5M256,6033.38%+1.13pp3q+36.6%+$5.5M
ENLIVEN THERAPEUTICS INCELVN$18.5M365,3863.06%+1.02pp3q+122.8%+$10.2M
ABIVAX SAABVX$14.8M111,3342.45%+0.93pp3q+158.6%+$9.1M
AVALO THERAPEUTICS INCAVTX$14.2M770,7652.35%+1.34pp3q+260.5%+$10.3M
MIRUM PHARMACEUTICALS INCMIRM$12.9M110,3932.13%-newNEW
ASSEMBLY BIOSCIENCES INCASMB$11.9M433,1471.96%+1.47pp3q+671.5%+$10.4M
CENTURY THERAPEUTICS INCIPSC$10.7M4,347,8261.76%-0.36pp2q+47.5%+$3.4M
CYTOKINETICS INCCYTK$10.1M118,2401.66%+0.38pp3q+93.0%+$4.9M
TAYSHA GENE THERAPIES INCTSHA$9.9M1,504,4001.64%+0.75pp3q+140.4%+$5.8M
VERADERMICS INCMANE$9.8M80,0001.62%-newNEW
ARRIVENT BIOPHARMA INCAVBP$8.6M246,6061.41%+1.05pp2q+390.7%+$6.8M
TARSUS PHARMACEUTICALS INCTARS$7.9M117,0671.31%+0.86pp3q+491.2%+$6.6M
XENCOR INCXNCR$7.8M368,3051.29%+0.99pp3q+360.4%+$6.1M
ROIVANT SCIENCES LTDROIV$7.8M220,1261.29%+0.16pp2q+71.7%+$3.3M
DAMORA THERAPEUTICS INCDMRA$7.4M284,4301.22%+0.39pp2q+180.9%+$4.8M
AXSOME THERAPEUTICS INCAXSM$7.1M28,8261.16%+0.41pp3q+105.1%+$3.6M
DEFINIUM THERAPEUTICS INCDFTX$7.0M148,6471.15%+0.55pp2q+48.8%+$2.3M
DIANTHUS THERAPEUTICS INCDNTH$6.3M64,7231.04%-0.40pp3q+19.3%+$1.0M
COGENT BIOSCIENCES INCCOGT$5.7M147,5100.94%-0.88pp3q-1.3%-$73.1K
ERASCA INCERAS$5.6M308,0070.93%-0.21pp2q+38.5%+$1.6M
PROTAGONIST THERAPEUTICS INCPTGX$5.6M45,4000.92%+0.78pp3q+1035.0%+$5.1M
MINERVA NEUROSCIENCES INCNERV$5.6M1,001,3730.92%+0.44pp2q+303.0%+$4.2M
EDITAS MEDICINE INCEDIT$4.3M1,330,5000.71%-newNEW
CYTOMX THERAPEUTICS INCCTMX$4.1M1,085,3980.67%+0.12pp3q+192.2%+$2.7M
EUPRAXIA PHARMACEUTICALS INCEPRX$4.0M610,7850.67%-0.33pp2q+40.9%+$1.2M
SUTRO BIOPHARMA INCSTRO$3.8M159,1180.63%-newNEW
RELAY THERAPEUTICS INCRLAY$3.3M178,2220.55%-0.26pp3q-30.9%-$1.5M
CELLDEX THERAPEUTICS INC NEWCLDX$3.2M86,6640.53%+0.24pp2q+195.8%+$2.1M
ASCENDIS PHARMA A/SASND$3.2M11,8690.52%-newNEW
SAGIMET BIOSCIENCES INCSGMT$3.1M403,5450.51%-newNEW
ZAI LAB LTDZLAB$2.9M136,0160.48%+0.02pp2q+74.7%+$1.3M
SAB BIOTHERAPEUTICS INCSABS$2.9M736,0770.47%+0.35pp2q+636.1%+$2.5M
MADRIGAL PHARMACEUTICALS INCMDGL$2.7M4,9730.44%-0.12pp3q+46.6%+$848.4K
PRAXIS PRECISION MEDICINES IPRAX$2.5M7,5400.42%-newNEW
RELMADA THERAPEUTICS INCRLMD$2.4M348,2650.40%-newNEW
AGIOS PHARMACEUTICALS INCAGIO$2.1M56,9000.35%-1.90pp3q-72.8%-$5.7M
XENON PHARMACEUTICALS INCXENE$2.1M33,3000.34%-newNEW
SAVARA INCSVRA$1.9M309,1030.31%-0.20pp3q+4.5%+$82.6K
C4 THERAPEUTICS INCCCCC$1.8M381,1690.29%+0.25pp2q+567.8%+$1.5M
VAXCYTE INCPCVX$1.8M29,8000.29%-1.71pp3q-72.5%-$4.7M
CELCUITY INCCELC$1.7M16,2520.28%+0.06pp3q+170.9%+$1.1M
SYNDAX PHARMACEUTICALS INCSNDX$1.6M77,9300.27%-newNEW
ZENTALIS PHARMACEUTICALS INCZNTL$1.5M317,6000.24%+0.16pp2q+188.7%+$948.7K
STRUCTURE THERAPEUTICS INCGPCR$1.4M26,8000.24%+0.10pp2q+197.8%+$957.5K
LEONABIO INCLONA$1.4M154,1530.23%-0.30pp3q-6.4%-$96.7K
IDEAYA BIOSCIENCES INCIDYA$1.4M37,8650.23%-0.68pp2q-56.1%-$1.8M
GERON CORPGERN$1.4M1,057,2280.22%+0.02pp3q+149.2%+$810.3K
ADLAI NORTYE LTDANL$1.3M113,2070.21%-newNEW
CORVUS PHARMACEUTICALS INCCRVS$1.2M82,8900.20%-0.18pp2qHELD
ALKERMES PLCALKS$1.2M23,2850.20%-0.07pp2q-3.7%-$46.4K
SPYRE THERAPEUTICS INCSYRE$1.2M13,3000.19%-0.12pp2q-32.5%-$567.3K
PERSPECTIVE THERAPEUTICS INCCATX$1.1M332,6130.19%-0.31pp2q-12.3%-$158.5K
ONKURE THERAPEUTICS INCOKUR$1.1M240,9630.18%-newNEW
SUMMIT THERAPEUTICS INCSMMT$1.1M73,3000.18%-newNEW
AN2 THERAPEUTICS INCANTX$1.0M208,9460.17%-0.05pp2q+4.6%+$44.7K
CONTINEUM THERAPEUTICS INCCTNM$992.3K60,5410.16%+0.05pp2q+123.8%+$548.9K
TREVI THERAPEUTICS INCTRVI$833.4K45,5980.14%+0.03pp3q+68.0%+$337.2K
VOYAGER THERAPEUTICS INCVYGR$771.9K230,4060.13%-0.01pp2q+100.0%+$385.9K
INVENTIVA SAIVA$756.5K200,1410.12%-0.23pp2qHELD
Engene Therapeutics IncENGN$711.1K411,0650.12%-newNEW
LARIMAR THERAPEUTICS INCLRMR$704.3K230,9210.12%-0.25pp2q-10.0%-$78.3K
INHIBIKASE THERAPEUTICS INCIKT$704.2K346,9000.12%-0.06pp3q+6.5%+$43.2K
NEUROGENE INCNGNE$693.8K22,0600.11%-newNEW
ISHARES TRIHI$681.9K13,8000.11%-newNEW
SILENCE THERAPEUTICS PLCSLN$660.0K60,1070.11%-0.15pp3q-61.7%-$1.1M
KRYSTAL BIOTECH INCKRYS$659.3K1,7740.11%-0.25pp3q-58.9%-$944.8K
OPUS GENETICS INCIRD$588.3K143,1370.10%-0.10pp2q+6.6%+$36.6K
PALISADE BIO INCPALI$568.9K272,2040.09%-0.02pp3q+27.7%+$123.5K
EVOLUS INCEOLS$541.7K78,0570.09%-0.01pp3qHELD
UNICYCIVE THERAPEUTICS INCUNCY$521.1K103,4000.09%-0.03pp2q+85.6%+$240.4K
COMPASS THERAPEUTICS INCCMPX$510.4K233,0660.08%-0.78pp3q-54.9%-$621.8K
BIOCRYST PHARMACEUTICALS INCBCRX$510.2K51,0240.08%-0.23pp2q-50.2%-$514.7K
BRIGHT MINDS BIOSCIENCES INCDRUG$448.9K6,3950.07%-0.07pp2qHELD
PROTHENA CORP PLCPRTA$423.9K43,3000.07%-0.06pp3qHELD
MONTE ROSA THERAPEUTICS INCGLUE$406.6K16,8000.07%-0.05pp3q-25.4%-$138.7K
OLEMA PHARMACEUTICALS INCOLMA$393.8K31,4760.06%-newNEW
MILESTONE PHARMACEUTICALS INMIST$362.1K270,2330.06%-0.07pp2q-18.9%-$84.6K
ENTERA BIO LTDENTX$338.7K191,3540.06%-0.02pp3q-6.9%-$25.1K
CUE BIOPHARMA INCCUE$337.8K10,7020.06%-newNEW
MBX BIOSCIENCES INCMBX$331.2K6,0000.05%-newNEW
BEAM THERAPEUTICS INCBEAM$302.2K8,8040.05%-0.02pp3qHELD
ASTRAZENECA PLCAZN$265.5K1,4000.04%-newNEW
AMYLYX PHARMACEUTICALS INCAMLX$261.1K14,5400.04%-0.03pp3q-12.8%-$38.3K
STOKE THERAPEUTICS INCSTOK$255.4K7,7450.04%-newNEW
VIKING THERAPEUTICS INCVKTX$251.9K7,4040.04%-newNEW
LIPOCINE INC NEWLPCN$201.8K78,8420.03%-0.28pp2q-36.9%-$118.0K
CORBUS PHARMACEUTICALS HLDGSCRBP$201.0K21,4320.03%-0.22pp3q-75.0%-$602.7K
PROMIS NEUROSCIENCES INCPMN$139.5K10,6000.02%-0.02pp2qHELD
WAVE LIFE SCIENCES LTDWVE$99.8K19,0480.02%-newNEW
PMV PHARMACEUTICALS INCPMVP$71.8K53,5690.01%-0.01pp3q-15.6%-$13.3K
FULCRUM THERAPEUTICS INCFULC$66.2K18,0890.01%-0.08pp2q-52.5%-$73.2K
UNIQURE NVQURE$15.3K3380.00%-newNEW

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 99.6%Other sectors 0.3%Not classified 0.1%
 
SectorValueShare
Biotech & Pharma$603.5M99.6%
Other sectors$1.7M0.3%
Not classified$681.9K0.1%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$605.9M962443224265.1%48
Q1 2026$315.1M1145836172951.8%45
Q4 2025$147.8M85000068.4%92

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.